NRTI now squarely focused on Nulief and their CBD
Post# of 1040
Posted On: 04/29/2015 11:34:12 AM
NRTI now squarely focused on Nulief and their CBD Initiative! - Per yesterday's PR that gave us renewed optimism for a faster retail rollout.
Nulief is a hemp based CBD obtained outside the US and exempt from the Schedule 1 restrictions set by the DEA and therefore perfectly legal to sell and ship to all 50 states. This was legal precedent set in federal court that provides the company with all the assurances needed to remove any grey areas.
When you do utilize the time and money to develop such a promising blockbuster brand like Nulief with huge potential and little to no competition at retail, you have to develop the right marketing plan to take advantage of a crucial timing situation in the market to maximize sales and profits to receive proper recognition. Shareholders are only interested in winners and when they serve up a proven winning brand is when the company and shareholders will get rewarded and Nulief is the brand that has all the potential to become that proven winner.
Management has developed the perfect brand to take the retail market by storm and now they have to develop an aggressive marketing strategy to make it into a real blockbuster! The opportunity and potential exist RIGHT NOW and the market is waiting to see what they will do to take advantage of this situation. If they can get aggressive in the coming months to roll out Nulief to the retail trade, they will get noticed in a big way and in turn their share price will appreciate quickly. But if they in turn move at a snails pace, the opportunity could be lost forever.
Yesterday's PR was a great preview of what they have coming that could change everything here. This quote from CEO, Michael James, was the most impactful piece of the whole PR "We are committed to expanding the Nulief brand into a portfolio of breakthrough supplements that are available in mainstream retail outlets." This is the key to their future success, getting the Nulief brand in mainstream retail outlets. If in fact they are committed, we should see a whole lot of exciting things taking place in the coming months. The day they announce a retail distribution deal for Nulief at a large chain, is when this stock explodes to the upside. This is what their stockholders have been waiting for all along.
I may have been critical of how they operate, but sometimes it requires one to make some bold moves to make them realize certain opportunities that exist in the market that they need to act upon. They also need to be made aware of what the market and investors are interested in. I know it has caused some extreme friction between me and management, but in the end all that matters is the actions they take to turn things around. My approach may very well have hit a few nerves that caused them to take a defensive posture in the beginning, but I think it also caused them to re-evaluate their action plan with Nulief, which is all that I could ask for. As long they keep moving forward with Nulief as their #1 priority, I will be a strong supporter, but as you all know by now, I will tell it like it is.
Once again I have renewed optimism for Inergetics, as I believe the Nulief brand will be the huge winner to take this company to new heights. When you consider what their CBD Initiative involves, it isn't hard to get excited about what the future here holds.
Nulief is a Best-In-Class Quality CBD product created with the help of some of the top experts who have worked and studied in the medical marijuana field for a very long time.
The high quality ingredients free from contaminates, precise measuring, state of the art extraction, and extreme quality control, manufactured under the NSF guidelines, assures a consistent safe and efficacious product for each and every package produced. This will go a long way in helping to set the new industry standard and make them the CBD market leader in retail stores.
Consumers and physicians alike will feel comfortable and safe enough to buy and recommend this quality CBD product, something that has been missing in the entire CBD market.
Cheers!
Nulief is a hemp based CBD obtained outside the US and exempt from the Schedule 1 restrictions set by the DEA and therefore perfectly legal to sell and ship to all 50 states. This was legal precedent set in federal court that provides the company with all the assurances needed to remove any grey areas.
When you do utilize the time and money to develop such a promising blockbuster brand like Nulief with huge potential and little to no competition at retail, you have to develop the right marketing plan to take advantage of a crucial timing situation in the market to maximize sales and profits to receive proper recognition. Shareholders are only interested in winners and when they serve up a proven winning brand is when the company and shareholders will get rewarded and Nulief is the brand that has all the potential to become that proven winner.
Management has developed the perfect brand to take the retail market by storm and now they have to develop an aggressive marketing strategy to make it into a real blockbuster! The opportunity and potential exist RIGHT NOW and the market is waiting to see what they will do to take advantage of this situation. If they can get aggressive in the coming months to roll out Nulief to the retail trade, they will get noticed in a big way and in turn their share price will appreciate quickly. But if they in turn move at a snails pace, the opportunity could be lost forever.
Yesterday's PR was a great preview of what they have coming that could change everything here. This quote from CEO, Michael James, was the most impactful piece of the whole PR "We are committed to expanding the Nulief brand into a portfolio of breakthrough supplements that are available in mainstream retail outlets." This is the key to their future success, getting the Nulief brand in mainstream retail outlets. If in fact they are committed, we should see a whole lot of exciting things taking place in the coming months. The day they announce a retail distribution deal for Nulief at a large chain, is when this stock explodes to the upside. This is what their stockholders have been waiting for all along.
I may have been critical of how they operate, but sometimes it requires one to make some bold moves to make them realize certain opportunities that exist in the market that they need to act upon. They also need to be made aware of what the market and investors are interested in. I know it has caused some extreme friction between me and management, but in the end all that matters is the actions they take to turn things around. My approach may very well have hit a few nerves that caused them to take a defensive posture in the beginning, but I think it also caused them to re-evaluate their action plan with Nulief, which is all that I could ask for. As long they keep moving forward with Nulief as their #1 priority, I will be a strong supporter, but as you all know by now, I will tell it like it is.
Once again I have renewed optimism for Inergetics, as I believe the Nulief brand will be the huge winner to take this company to new heights. When you consider what their CBD Initiative involves, it isn't hard to get excited about what the future here holds.
Nulief is a Best-In-Class Quality CBD product created with the help of some of the top experts who have worked and studied in the medical marijuana field for a very long time.
The high quality ingredients free from contaminates, precise measuring, state of the art extraction, and extreme quality control, manufactured under the NSF guidelines, assures a consistent safe and efficacious product for each and every package produced. This will go a long way in helping to set the new industry standard and make them the CBD market leader in retail stores.
Consumers and physicians alike will feel comfortable and safe enough to buy and recommend this quality CBD product, something that has been missing in the entire CBD market.
Cheers!
(0)
(0)Inergetics Inc. (NRTI) Stock Research Links
Scroll down for more posts ▼